Page last updated: 2024-11-03

primaquine and Takayasu Arteritis

primaquine has been researched along with Takayasu Arteritis in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Takayasu Arteritis: A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with aortitis syndrome often exhibit retinopathy.

Research Excerpts

ExcerptRelevanceReference
"Takayasu arteritis, also known as "pulseless disease," causes proximal occlusion of the lumen of large arteries of the neck and arm, leading to impalpable pulses and "pseudohypotension."1.46A Curious Case of "Septic Shock". ( Jain, S; Kumari, S; Lakshman, A; Sharma, N; Singh, C; Singhal, M; Varma, S, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lakshman, A1
Singh, C1
Singhal, M1
Jain, S1
Sharma, N1
Kumari, S1
Varma, S1

Other Studies

1 other study available for primaquine and Takayasu Arteritis

ArticleYear
A Curious Case of "Septic Shock".
    The Journal of emergency medicine, 2017, Volume: 52, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Ceftriaxone; Drug Combination

2017